Bharat Biotech, which will soon be starting late-stage human trials of its Covid-19 vaccine on over 20,000 volunteers in India, is trying to ensure its candidate...
Covaxin: Bharat Biotech aims to improve clinical results by at least 60%, above regulator cut-off mark